Postmarketing Surveillance of Quinolones, 1990 to 1992
- 1 January 1993
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 45 (3) , 46-53
- https://doi.org/10.2165/00003495-199300453-00010
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Review of company postmarketing surveillance studies.BMJ, 1992
- Decision analysis in medicine.BMJ, 1992
- How Common are Epileptic Seizures in Old Age?Age and Ageing, 1991
- Spontaneous reporting: how many cases are required to trigger a warning? [see comments]British Journal of Clinical Pharmacology, 1991
- Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.BMJ, 1991
- WHAT DO PATIENTS AND RHEUMATOLOGISTS REGARD AS AN ‘ACCEPTABLE’ RISK IN THE TREATMENT OF RHEUMATIC DISEASE?Rheumatology, 1990
- Post-Marketing Surveillance of the Quinolones: A View from Great BritainClinical Infectious Diseases, 1989
- Serum Sickness-Like Reactions to Amoxicillin, Cefaclor, Cephalexin, and Trimethoprim-SulfamethoxazoleThe Journal of Infectious Diseases, 1988
- Adverse and beneficial effects of immediate treatment of Group A beta-hemolytic streptococcal pharyngitis with penicillinThe Pediatric Infectious Disease Journal, 1987
- Willingness to pay and accept risks to cure chronic disease.American Journal of Public Health, 1986